http://rdf.ncbi.nlm.nih.gov/pubchem/reference/16961770
Outgoing Links
Predicate
Object
contentType
Journal Article
endingPage
216
issn
1837-9664
issueIdentifier
1
pageRange
207-216
publicationName
Journal of Cancer
startingPage
207
bibliographicCitation
Li J, Zou Y, Pei M, Zhang Y, Jiang Y. Berberine inhibits the Warburg effect through TET3/miR-145/HK2 pathways in ovarian cancer cells. J Cancer. 2021;12(1):207–16. PMID: 33391417; PMCID: PMC7738813.
creator
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0a0c37dcaa713af32dce94edd06833b7
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d66689589ed2f8e17b145f3a42fdb319
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_761380b87960160c823cff1f7fd12444
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4f29941cf138848bf1d0f04696a784ac
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9137fe389d3788dfc8786b5f58f9a09a
date
2021
identifier
https://pubmed.ncbi.nlm.nih.gov/33391417
https://pubmed.ncbi.nlm.nih.gov/PMC7738813
https://doi.org/10.7150/jca.48896
isPartOf
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/37885
https://portal.issn.org/resource/ISSN/1837-9664
language
English
source
https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
title
Berberine inhibits the Warburg effect through TET3/miR-145/HK2 pathways in ovarian cancer cells
discussesAsDerivedByTextMining
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID612
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID104748
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_b33ff0477422408adbb3ad38bb6cfd11
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5793
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2353
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID91435
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_a54e25d94fe5cbd65fa2ff730a02d4a1
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_cb94a226bbdff7de9a1d9222f4a18ade
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/EC_1.13.12.8
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8752
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607
Total number of triples:
34
.